| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,660,700 | 1,645,300 | 1,786,500 | 2,291,500 | | Cost of Revenue | 945,500 | 976,900 | 1,115,700 | 634,900 | | | Gross Profit | 715,200 | 668,400 | 670,800 | 1,656,600 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 105,600 | 93,300 | 120,600 | 1,126,400 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 202,900 | 203,100 | 210,200 | 212,200 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 406,700 | 372,000 | 340,000 | 318,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,600 | 21,600 | 9,300 | (7,000) | | Earnings Before Interest And Taxes | 475,100 | 435,500 | 387,500 | 350,800 | | Interest Expense | 100,100 | 98,900 | 97,200 | 100,100 | | Income Before Tax | 375,000 | 336,600 | 290,300 | 250,700 | | Income Tax Expense | 11,300 | 8,000 | 23,500 | (15,400) | | Minority Interest | (11,900) |
-
|
-
| (2,500) | | | | Net Income From Continuing Ops | 351,800 | 328,600 | 266,800 | 266,100 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 351,800 | 328,600 | 266,800 | 266,100 | | Preferred Stock And Other Adjustments | 7,700 | (4,800) | (2,900) |
-
| | | Net Income Applicable To Common Shares | $359,500 | $323,800 | $263,900 | $266,100 |
|
0.11% Nasdaq 
0.01%
Income Statement
